Generics 21

Originals

Biosimilars

Medical devices

Nutraceuticals

Filters

Atomoxetine manufacturers

21 products found

Filters

21 products found

atomoxetine

Oral solution 4 mg/ml

Dossier type
EU CTD
Dossier status
Ready to file
Country of origin
European Union
GMP approvals
EU GMP
Unavailable markets
France , Germany , Italy , Portugal , Spain , United Kingdom , Vietnam
Manufacturer #437
A pharmaceutical manufacturer based in the EU that is active in 40+ countries selling its products in Europe, North America, LATAM, Africa, Middle East, and Asia for 40+ years. Main therapeutics areas include the nervous system, cardiometabolic, and women’s health. The company's production lines are GMP-compliant. The main dosage forms are solid, semi-solid, liquid, and suspension. The company owns branches in the EU, Africa, and LATAM.

Manufacturer usually replies in 10 days

atomoxetine

Capsules 10 mg, 18 mg, 25 mg, 40 mg, 60 mg, 80 mg, 100 mg

Dossier type
EU CTD
Dossier status
Ready to file
Country of origin
European Union
GMP approvals
EU GMP
Unavailable markets
Ireland , Malta , Portugal , Vietnam
Manufacturer #437
A pharmaceutical manufacturer based in the EU that is active in 40+ countries selling its products in Europe, North America, LATAM, Africa, Middle East, and Asia for 40+ years. Main therapeutics areas include the nervous system, cardiometabolic, and women’s health. The company's production lines are GMP-compliant. The main dosage forms are solid, semi-solid, liquid, and suspension. The company owns branches in the EU, Africa, and LATAM.

Manufacturer usually replies in 10 days

atomoxetine

Capsules 10 mg , 18 mg, 25 mg, 40 mg, 60 mg, 80 mg, 100 mg

Dossier type
EU CTD
Dossier status
Ready to file
Country of origin
India
GMP approvals
EU GMP
Registered in
Germany , Portugal , Spain
MAs for sale
Portugal , Spain
Manufacturer #15189
The company, which was founded in 1989, is involved in developing, manufacturing, and distributing a wide range of formulations for anti-infectives, cardiovascular, anti-diabetic, dermatological, and hormone treatment. The corporation has a global presence in 170 + countries, 60+ WHO-prequalified medications, and 3700+ product registrations.

Manufacturer usually replies in 9 days

atomoxetine

Tablets 18 mg, 25 mg, 40 mg, 60 mg, 80 mg , 100 mg

Dossier type
US CTD
Dossier status
Ready to file
Country of origin
Israel
GMP approvals
EU GMP
Registered in
Israel
Available for
Licensing with supply
Manufacturer #8558
A pharmaceutical manufacturer that has been active for 40+ years. The company's production lines are EU GMP-compliant. The company product is prepared in CTD dossier format. The main dosage forms oral solid. The main therapeutic areas include mental health, cardiology, and urology.

Manufacturer usually replies in 6 days

atomoxetine

Capsules 10 mg, 18 mg, 25 mg, 40 mg, 60 mg, 80 mg, 100 mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
Canada
GMP approvals
Canada
Manufacturer #17783
It is a pharmaceutical company that began operations in the 2000s in North America and sells a wide selection of generic pharmaceuticals while continuing to expand its portfolio. They try to deliver accessible solutions for patient safety through continuing innovation such as simpler packaging and important safety features. They are laser-focused on developing cutting-edge solutions to ensure that patients have access to high-quality pharmaceuticals.

Manufacturer usually replies in 9 days

atomoxetine

Capsules 10 mg, 18 mg, 25 mg, 60 mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
Canada
GMP approvals
Canada
Manufacturer #17782
Over 40 years ago, it was founded in North America. The company has long been a leader in the generic product manufacturing industry. It has earned a name for itself in the production of branded and over-the-counter private label items. Customers are actively and attentively listened to by the company. They anticipate the evolution of new markets and are ready to adapt to new medical needs.

Manufacturer usually replies in 7 days

atomoxetine

Capsules 10mg, 18mg, 25mg,40mg,60mg, 80mg,100mg

Dossier type
EU CTD
Dossier status
Ready to file
Country of origin
India
GMP approvals
EU GMP
Available for
Licensing with supply, Distribution only
Comments
Interested in projects only for European markets.
Manufacturer #15224

Manufacturer usually replies in 7 days

atomoxetine

Oral solution 4 mg/ml - 100 ml

Dossier type
CTD
Dossier status
Ready to file
Country of origin
Israel
GMP approvals
EU GMP
Registered in
Israel
Available for
Licensing with supply
Manufacturer #8558
A pharmaceutical manufacturer that has been active for 40+ years. The company's production lines are EU GMP-compliant. The company product is prepared in CTD dossier format. The main dosage forms oral solid. The main therapeutic areas include mental health, cardiology, and urology.

Manufacturer usually replies in 6 days

atomoxetine

Capsules 10 mg, 18 mg, 25 mg , 40 mg, 60 mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
Canada
GMP approvals
Canada
Comments
Reference product : Strattera (Lilly)
Manufacturer #278

The company has become a prominent partner of the pharmacy community in North America, with the fastest rising market share among generic leaders. It can provide best-in-class supply reliability thanks to production capacity. In more than 50 countries, it's available locally or through corporate partnerships. R&D expenditures range from $40 million to $50 million per year. They are dedicated to maintaining a customer satisfaction rate of over 95% by continuously enhancing supply chain efficiency.

Manufacturer usually replies in 7 days

atomoxetine

Tablets 10 mg, 25 mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
Egypt
GMP approvals
Egypt
Manufacturer #21899

Manufacturer usually replies in 1 days

atomoxetine

Capsules 25 mg, 40 mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
Pakistan
GMP approvals
Sri Lanka, Afghanistan, Vietnam, Cambodia, Myanmar
Manufacturer #21102

Manufacturer usually replies in 5 days

atomoxetine

Tablets 10 mg, 180 mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
India
GMP approvals
WHO
Manufacturer #20045

Manufacturer usually replies in 2 days

atomoxetine

Capsules 40 mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
India
GMP approvals
WHO
Manufacturer #19698

Manufacturer usually replies in 3 days

atomoxetine

Tablets 10 mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
India
GMP approvals
WHO
Manufacturer #18530

Manufacturer usually replies in 4 days

atomoxetine

Capsules 10 mg, 18 mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
India
GMP approvals
WHO
Manufacturer #18285

Manufacturer usually replies in 3 days

atomoxetine

Vials, injection 0.3 mg / 1 ml

Dossier type
CTD
Dossier status
Ready to file
Country of origin
Mexico
GMP approvals
FDA
Manufacturer #8698
It has a multi-purpose chemical and pharmaceutical plant with over 17 years of experience producing Active Pharmaceutical Ingredients (APIs). The company aims to be a leader in the creation of active pharmaceutical ingredients for human health care, with the quality, service, and pricing that enable it to compete internationally and improves the quality of life for the patients of the company.

Manufacturer usually replies in 6 days

atomoxetine

Capsules 40 mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
Mexico
GMP approvals
FDA
Manufacturer #8698
It has a multi-purpose chemical and pharmaceutical plant with over 17 years of experience producing Active Pharmaceutical Ingredients (APIs). The company aims to be a leader in the creation of active pharmaceutical ingredients for human health care, with the quality, service, and pricing that enable it to compete internationally and improves the quality of life for the patients of the company.

Manufacturer usually replies in 6 days

atomoxetine

Capsules 5 mg, 10 mg, 18 mg, 25 mg, 40 mg, 60 mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
India
GMP approvals
WHO
Manufacturer #20401

Manufacturer usually replies in 5 days

atomoxetine

Capsules 10 mg , 18 mg, 25 mg , 40 mg , 60 mg , 80 mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
Turkey
GMP approvals
PICS
Manufacturer #16875
In the 1920s, it was one of 150+ firms founded in southeast Europe. In its early years, it manufactured and marketed pharmaceutical items under the licensing of global corporations. In the early 1980s, the company began importing completed pharmaceutical items and manufacturing and marketing identical products, establishing itself as a major participant in the local pharmaceutical industry. For more than 50 years, it has provided the pharmaceutical business with more than 210 different pharmaceutical goods, over 70 brands, and the manufacture of high-quality drugs, and continues to work with international companies.

Manufacturer usually replies in 6 days

atomoxetine

Capsules 10 mg, 18 mg, 25 mg, 40 mg, 60 mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
Jordan
GMP approvals
Jordan, EU GMP
Manufacturer #20767
It is a multinational pharmaceutical company specializing in the development, production, and distribution of generic and specialty medicines. They have a broad technology base covering OSD, liquids, creams, ointments, and sterile (injectable) across all key therapeutic areas. They have a further 90+ products (INNs) under development and registration. They aim to improve the quality of life by increasing access to high-quality and affordable medicines.

Manufacturer usually replies in 11 days

Want to view all 21 products? Create your free account today!

Atomoxetine Manufacturers

Atomoxetine is a CNS stimulant class medication that is used to treat attention deficit hyperactivity disorder, depression, fibromyalgia, and social anxiety. Suppliers of atomoxetine medications market it in the form of 10mg, 18mg, 25mg, 40mg, 60mg, 80mg, and 100mg capsules. The main alternatives to atomoxetine are other CNS stimulants, such as methylphenidate, dextroamphetamine, and lisdexamfetamine. Atomoxetine differs in the mechanism of action compared to these medications, which are all associated with increased side-effects and risk of dependency. Consequently, atomoxetine can be said to have a superior safety profile to these substitute drugs. Following FDA approval for medical use in 2002, the earliest atomoxetine manufacturer and patent-filing company Eli Lilly began marketing the drug under the trade name Strattera. The producer’s patent, however, expired in 2010, paving the way for other manufacturers and atomoxetine suppliers. Companies Sandoz, Mylan, Teva, Greenstone, and Sun Pharma have since introduced their atomoxetine medications into the global pharmaceutical market. The drug has gained popularity throughout the years and has become widely prescribed, with over 2 million prescriptions registered yearly in the U.S. alone. Consequently, atomoxetine suppliers and distributors currently market both generic and trade name formulations of the drug.

How Does Atomoxetine Work?

Atomoxetine is known to be a potent and selective inhibitor of the norepinephrine transporter (NET), which prevents cellular reuptake of norepinephrine throughout the brain, which is thought to improve the symptoms of ADHD. More recently, positron emission tomography (PET) imaging studies in rhesus monkeys have shown that atomoxetine also binds to the serotonin transporter (SERT),9 and blocks the N-methyl-d-aspartate (NMDA) receptor,10 indicating a role for the glutamatergic system in the pathophysiology of ADHD. The pharmacokinetic profile of atomoxetine is highly dependent on cytochrome P450 2D6 genetic polymorphisms of the individual. A large fraction of the population (up to 10% of Caucasians and 2% of people of African descent and 1% of Asians) are poor metabolizers (PMs) of CYP2D6 metabolized drugs. These individuals have reduced activity in this pathway resulting in 10-fold higher AUCs, 5-fold higher peak plasma concentrations, and slower elimination of atomoxetine compared with people with normal CYP2D6 activity.

Wholesale Price of Atomoxetine

Based on the drugstore you go to, a 30-capsule prescription of atomoxetine oral capsule 25 mg costs about $117. Costs of Atomoxetine vary depending on manufacturer and supplier pricing, whether it is a generic or trade name formulation, concentration of the active ingredient in the formulation. Atomoxetine is available for sale from various Atomoxetine vendors at multiple costs. Prices are applicable just for cash consumers and do not apply to insurance policies. Atomoxetine suppliers, on the whole, are in favor of patient aid initiatives. This cost may differ among dealers.

From Where to Get Atomoxetine?

Buyers are advised that online sellers may attempt to market fraudulent versions of the generic drug, whereas Pipeline Pharma, through its pre-auditing and quality control procedures ensures that only verified Atomoxetine manufacturers and wholesalers enter our online marketplace, offering you a risk-free B2B pharmaceutical sales platform. PipelinePharma is the most reliable source for this medication. Finding an honest partner in our business is one of the significant challenges. To overcome this challenge and make one's life easier when looking for a direct manufacturer and supplier of Atomoxetine, one can go to the Pipelinepharma website, which assists buyers in locating dependable manufacturers and suppliers of Atomoxetine.

Navigating our Pharmaceutical Marketplace

Being a global B2B pharmaceutical online marketplace, Pipelinepharma is structured to simplify pharmaceutical deals by providing you with an intuitive interface that is easy to engage with. The selection of Atomoxetine offerings can be narrowed down with filters and easily weighed against one another according to medication prices and commercial terms. The advanced filters help you filter out the countries for this substance manufacturer and Atomoxetine suppliers that you are looking for. These also enable you to check the dossier status of this medicine and the GMP approvals of the different variants of Atomoxetine. Also, each manufacturer or supplier product description contains essential information about this substance, including clinical data, stability zones, and countries in which Atomoxetine is already registered. Manufacturers also have special delivery terms.

Establishing Commercial Ties

Suppose you are a pharmaceutical licensing company or a distributor. In that case, you can enter into deals or negotiations over these medicine offers with manufacturing companies after completing the free registration process and joining our online marketplace. This helps ensure that you conclude the pharmaceutical deal at a reasonable cost and achieve the best cost/benefit ratio for your company while bypassing lengthy sourcing, negotiation, and order process. Once you have finalized a deal, you can look forward to a long-lasting business relationship with the Atomoxetine suppliers. This way, the marketplace allows you as a distributor to skip the process of making a list of product manufacturers every time you are looking for in-licensing or distribution deals.

Quality Assurance

To keep up to the quality standards other than Good Manufacturing Practice approvals that this medicine manufacturers list has, we qualify their companies before they are boarded on the platform. This allows us to screen Atomoxetine manufacturers for the quality of the pharmaceutical products' dossiers and protect against the risk of possible malpractices.